Antioxidant rich grape pomace extract suppresses postprandial hyperglycemia in diabetic mice by specifically inhibiting alpha-glucosidase.
BACKGROUND
Postprandial hyperglycemia is an early defect of type 2 diabetes and one of primary anti-diabetic targets. Treatment of postprandial hyperglycemia can be achieved by inhibiting intestinal α-glucosidase, the key enzyme for oligosaccharide digestion and further glucose absorption. Grape pomace is winemaking byproduct rich in bioactive food compounds such as phenolic antioxidants. This study evaluated the anti-diabetic potential of two specific grape pomace extracts by determining their antioxidant and anti-postprandial hyperglycemic activities in vitro and in vivo.


METHODS
The extracts of red wine grape pomace (Cabernet Franc) and white wine grape pomace (Chardonnay) were prepared in 80% ethanol. An extract of red apple pomace was included as a comparison. The radical scavenging activities and phenolic profiles of the pomace extracts were determined through the measurement of oxygen radical absorbance capacity, DPPH radical scavenging activity, total phenolic content and flavonoids. The inhibitory effects of the pomace extracts on yeast and rat intestinal α-glucosidases were determined. Male 6-week old C57BLKS/6NCr mice were treated with streptozocin to induce diabetes. The diabetic mice were then treated with vehicle or the grape pomace extract to determine whether the oral intake of the extract can suppress postprandial hyperglycemia through the inhibition of intestinal α-glucosidases.


RESULTS
The red grape pomace extract contained significantly higher amounts of flavonoids and phenolic compounds and exerted stronger oxygen radical absorbance capacity than the red apple pomace extract. Both the grape pomace extracts but not the apple pomace extract exerted significant inhibition on intestinal α-glucosidases and the inhibition appears to be specific. In the animal study, the oral intake of the grape pomace extract (400 mg/kg body weight) significantly suppressed the postprandial hyperglycemia by 35% in streptozocin-induced diabetic mice following starch challenge.


CONCLUSIONS
This is the first report that the grape pomace extracts selectively and significantly inhibits intestinal α-glucosidase and suppresses postprandial hyperglycemia in diabetic mice. The antioxidant and anti-postprandial hyperglycemic activities demonstrated on the tested grape pomace extract therefore suggest a potential for utilizing grape pomace-derived bioactive compounds in management of diabetes.
Hogan
Shelly
S
Department of Nutrition and Food Science, Wayne State University, Detroit, MI, 48202, USA. kzhou@wayne.edu.
Zhang
Lei
L
Li
Jianrong
J
Sun
Shi
S
Canning
Corene
C
Zhou
Kequan
K
J Nutr. 1995 Jun;125(6):1554-62
7782910
Lancet. 2002 Jun 15;359(9323):2072-7
12086760
J Med Food. 2003 Winter;6(4):291-9
14977436
Biosci Biotechnol Biochem. 2007 Jan;71(1):69-76
17213665
Br J Nutr. 2004 Mar;91(3):357-65
15005821
Life Sci. 2002 Aug 9;71(12):1405-15
12127161
Bioresour Technol. 2008 Nov;99(17):8413-20
18445523
Bioresour Technol. 2008 May;99(8):2981-8
17706416
Gastroenterology. 1986 Jul;91(1):41-8
2423408
South Med J. 2001 Aug;94(8):804-9
11549192
Diabetes Obes Metab. 2001 Aug;3(4):240-8
11520303
J Agric Food Chem. 2004 Jan 28;52(2):234-8
14733501
Br J Nutr. 2007 Oct;98(4):702-10
17537288
Am J Clin Nutr. 2004 May;79(5):727-47
15113710
Metabolism. 2006 Jun;55(6):832-41
16713445
J Agric Food Chem. 2007 Jan 10;55(1):99-105
17199319
Biofactors. 2005;23(4):189-95
16498205
Am J Clin Nutr. 2002 Jul;76(1):266S-73S
12081850
J Agric Food Chem. 2004 Jul 14;52(14):4360-7
15237937
J Agric Food Chem. 2007 Feb 7;55(3):992-1002
17263504
J Agric Food Chem. 2007 May 2;55(9):3729-36
17411070
J Ethnopharmacol. 2005 Mar 21;97(3):497-501
15740886
J Cardiovasc Pharmacol. 2007 Oct;50(4):434-40
18049312
J Agric Food Chem. 1999 Feb;47(2):550-3
10563931
Menopause Int. 2007 Dec;13(4):165-9
18088528
Br J Biomed Sci. 1999;56(2):109-13
10695051
Diabetes Care. 2005 Jan;28(1):154-63
15616251
J Agric Food Chem. 2004 Oct 6;52(20):6108-14
15453674
Eur J Clin Invest. 1994 Aug;24 Suppl 3:3-10
8001624
Phytother Res. 2007 Aug;21(8):796-9
17533638
J Agric Food Chem. 2008 Sep 10;56(17):7781-9
18690694
Bioresour Technol. 2004 Apr;92(2):201-8
14693454
J Agric Food Chem. 2004 Nov 3;52(22):6779-86
15506816
Crit Rev Food Sci Nutr. 1995 Jul;35(4):341-71
7576162
Clin Exp Pharmacol Physiol. 2006 Apr;33(4):351-7
16620300
Poult Sci. 2008 Feb;87(2):307-16
18212374
J Agric Food Chem. 2007 Dec 12;55(25):10200-7
17999462
Med Hypotheses. 2005;65(1):152-4
15893133
J Biol Chem. 1995 Nov 10;270(45):26778-81
7592915
Nutrition. 2005 Jun;21(6):756-61
15925302
J Nutr. 1989 Dec;119(12):2023-9
2695605
Diabetes Res Clin Pract. 2007 Jul;77(1):41-6
17098323
Waste Manag. 2008;28(2):372-80
17433659
J Pediatr Endocrinol Metab. 2003 Jan;16(1):5-22
12585335
J Org Chem. 2008 Apr 18;73(8):3070-7
18345685
J Biol Chem. 1997 Jan 17;272(3):1601-7
8999834
Mayo Clin Proc. 1987 Apr;62(4):249-55
2436011
J Agric Food Chem. 2002 Oct 9;50(21):5909-14
12358458
J Anim Physiol Anim Nutr (Berl). 2007 Aug;91(7-8):289-96
17614999
J Enzyme Inhib Med Chem. 2009 Feb;24(1):65-9
18615280
J Nutr. 2000 Aug;130(8S Suppl):2073S-85S
10917926
Carcinogenesis. 2006 Jul;27(7):1445-53
16474170